Article Details
Retrieved on: 2022-12-01 18:09:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Phase 1 study of fianlimab: A human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced NSCLC.
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here